In addition, HA also acts as a signaling component that transduces intracellular signaling pathways for invasiveness of GBM cells through its cognate receptors such as CD44, RHAMM, and ICAM-1 [5, 7, 8]. The gene discussed is CD44; the disease is glioblastoma.